Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

While it’s encouraging to see continued stability in hospitals’ financial well-being over the past 12 months, historically slim margins indicate hospitals are not yet in a fully sustainable position,” ...

A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...

We recently compiled a list of the Jim Cramer Recently Talked About These 11 S&P 500 Stocks. In this article, we are going to ...

Elevance Health is the only health insurance company of 10 Moody's Ratings evaluated that received a "positive" credit ...

Insurers will continue to grapple with medical costs in excess of reimbursement rates for Medicare Advantage and Medicaid, while commercial coverage also faces continued high medical costs.

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

Figure CEO Brett Adcock sees the potential to ship 100,000 humanoid robots over the next four years, and said that Figure is ...

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...